Antipsychotic Effects
Antipsychotic Effects - Related Videos
01:21
Antipsychotic Drugs: Therapeutic Uses and Side Effects
0 Views •
2024
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia. Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
07:35
Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
0 Views •
Cited by 8 •
2014
Approaches for testing the effects of antipsychotic drugs (APDs) in Caenorhabditis elegans are demonstrated. Assays are described for testing drug effects on development and viability and on pharyngeal pumping rate. These methods are also applicable for pharmacogenetic experiments with drug classes other than APDs.
12:00
Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
0 Views •
Cited by 1 •
2014
Using event-related EEG potentials (ERPs), we investigate the effects of antipsychotic medications on abnormal semantic brain activations in healthy individuals with schizotypal traits. We use ERPs to track distinct changes in brain activity, shedding insight into the cognitive processes associated with semantic categorization.
01:28
Psychosis and Antipsychotic Drugs: Overview
0 Views •
2024
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:21
Antipsychotic Drugs: Typical and Atypical Agents
0 Views •
2024
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
FAQs
D2 antagonism reduces dopamine signaling by preventing dopamine from activating D2 receptors, whereas partial agonism provides a more limited receptor effect. This distinction helps explain why antipsychotic medications can differ in their overall therapeutic profiles. In pharmacology, comparing these mechanisms is important because receptor activity influences symptom improvement as well as movement, endocrine, metabolic, and sedative effects.
Many newer agents affect serotonin 5-HT2A signaling in addition to dopamine D2 receptors. Their combined activity reflects the fact that antipsychotic effects do not arise from a single neurotransmitter pathway. Studying these receptor actions helps pharmacologists relate differences among medications to their potential effects on psychosis, mood stabilization, relapse prevention, and treatment-associated adverse effects.
Dopamine-related pathways contribute not only to psychotic symptoms but also to movement and hormone release, while additional neurotransmitter systems influence metabolism and sedation. Consequently, reducing psychosis can occur alongside extrapyramidal, endocrine, cardiometabolic, or sedative effects. This shared pathway biology makes adverse-effect monitoring an essential part of understanding antipsychotic pharmacology.
Their clinical relevance includes schizophrenia and related disorders, but some medications also provide mood stabilization or help prevent relapse in bipolar disorder and other conditions. These additional applications depend on the particular drug and its receptor actions. Pharmacologists therefore examine both the target symptoms and the broader therapeutic profile when relating a medication to a disorder.
Improvement in positive symptoms, such as hallucinations, delusions, and disorganized thinking, is a central outcome. Depending on the medication, evaluation may also include mood stabilization and relapse prevention. These outcomes should be considered together with extrapyramidal, endocrine, metabolic, and sedative effects, because symptom control alone does not describe the medication’s complete pharmacological impact.
Pharmacology connects receptor-level actions with observable therapeutic and unwanted effects. D2 activity helps explain changes in psychosis, while serotonin 5-HT2A and other neurotransmitter effects contribute to differences among newer agents. Comparing these mechanisms allows the therapeutic benefits, including symptom control or relapse prevention, to be considered alongside movement, hormone, metabolic, and sedation-related consequences.